ZIVO Bioscience, Inc. focuses on the research, development, and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains. Their innovative platform utilizes a unique algae culture that can be processed in various forms, such as powders or flakes, to enhance the nutritional profile of animal feed and human food products. The company emphasizes the sustainability and affordability of its algae-based solutions, which are non-GMO, antibiotic-free, and rich in protein, fiber, and essential vitamins. This robust algae strain is designed to promote health benefits, including improved immune response in livestock and support for cholesterol balance and joint health in humans.

The proprietary technology behind ZIVO's products includes a patented process for cultivating and extracting bioactive compounds from their algae strains. This process allows for the creation of high-value nutritional ingredients without the use of solvents or energy-intensive methods. The adaptability of their algae strain enables its application across various sectors, including animal nutrition and human dietary supplements. ZIVO's commitment to sustainable practices is evident in their cultivation methods, which utilize efficient solar energy capture, resulting in significantly higher energy efficiency compared to traditional agricultural sources. This positions ZIVO as a leader in the development of innovative, plant-based nutritional solutions.

United States

OTCQB: ZIVO. ZIVO Bioscience, Inc., is a research and development company with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent pending inventions for applications in human and animal health. Please visit www.zivobioscience.com for more information.

Zivo Bioscience

Company Details